NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Modernising Medical Microbiology and Big Infection Diagnostics > Oxford-based citizen science project reaches three million classifications in fight against antibiotic resistance

Oxford-based citizen science project reaches three million classifications in fight against antibiotic resistance

24 April 2020 · Listed under Modernising Medical Microbiology and Big Infection Diagnostics

The Bash the Bug citizen science project has achieved three million classifications, after seeing a rapid increase in participation over the last two months.

The Bash the Bug logo overlaid on the usernames of all its volunteers
The Bash the Bug logo overlaid on the usernames of all its volunteers

Hosted on the Zooniverse platform, Bash the Bug has over 20,000 volunteers worldwide helping researchers to understand and predict which strains of tuberculosis bacteria will be resistant to which antibiotics. The project is based in the University of Oxford’s Modernising Medical Microbiology Group and supported by the NIHR Oxford Biomedical Research Centre.

TB is one of the top 10 causes of death globally and it is estimated that around 10 million people fell ill with the disease in 2018 with around 1.5 million deaths.

Bash the Bug volunteers are asked to classify images of M. tuberculosis (the bacterium that causes TB) samples that have been tested with different antibiotics. The samples are collected through the international CRyPTIC project, which Bash the Bug contributes to. The researchers hope that through looking at the genome of each M.tuberculosis infection, hospitals around the world will be able to routinely rapidly and accurately predict which drugs will be effective against the disease.

Having reached two million classifications on 12 March 2020, almost three years since the project began, the Bash the Bug team were delighted when they then achieved three million classifications just 38 days later on 19 April. That’s a classification every three seconds on average.

Dr Philip Fowler, lead researcher for the project, said: “The huge increase in classifications done by our volunteers has meant we’ve caught up with the data being produced by all the CRyPTIC labs worldwide which will mean we will be able to release our first dataset on time. We’re grateful to all the volunteers who helped to achieve this, the work we are doing together is vital to develop more effective treatments for patients with drug-resistant TB around the world.”

To celebrate the milestone Dr Fowler has created an image of the Bash the Bug logo overlaid on the usernames of all its volunteers (pictured).

← Large-scale COVID-19 infection and antibody test study launched
Varying risk of COVID-19 to health workers revealed →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre